Oncology & Cancer
Study reveals mechanism of lung-cancer drug resistance
New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs.
Jan 19, 2012
0
0
